David Childs, MD

• Assistant Professor of Radiology
• Abdominal Imaging Section
• Wake Forest University School of Medicine
• Winston-Salem, North Carolina

Abnormal electrocardiogram findings that were not detectable before therapy were found in 5 symptoms norovirus purchase oxcarbazepine 300 mg with mastercard. In a large single institutional study medicine zoloft discount oxcarbazepine 300 mg mastercard, 25% of the anthracycline-treated group showed cardiac abnormalities medicine hat lodge purchase oxcarbazepine 150 mg without prescription. This has not been seen in these children symptoms urinary tract infection best buy for oxcarbazepine, however medicine wheel wyoming discount oxcarbazepine 300 mg buy, compared with children with acute lymphoblastic leukemia from a multicenter study. Immunotherapy105 is a potential challenge for the future, with the hope that the current research will transpire into future therapy, especially the characteristic expression of gene peptides and recognition by cellular and humoral immune responses, which acts as a potential target antigen in immunotherapeutic trials. Musculoskeletal System Another consequence of radiotherapy with the addition of chemotherapy is abnormal musculoskeletal development. In a long-term review (median follow-up 15 years), the percentages of patients who developed muscular hypoplasia, limblength inequality, kyphosis, and iliac wing hypoplasia were 16. It was first described in 1854 by Wiener, who reported a case of rhabdomyosarcoma in an adult with a tumor on the tongue. Surgical excision remained the mainstay of therapy until the 1950s, when Stobbe and Daregeon4 showed that outcomes could be improved with the addition of radiotherapy. This method was later modified by the introduction of high-dose radiotherapy in the 1960s. In the late 1950s and early 1960s, various chemotherapeutic agents were found to be beneficial, including vincristine, actinomycin D, and cyclophosphamide. They acted as the catalyst for modern-day multimodal therapy and the introduction of large multicenter trials on the treatment of rhabdomyosarcoma. Cure rates have improved substantially in the last 3 decades; there has been a steady increase in the 5-year survival from approximately 30% to 75% today. In addition, with modern multidisciplinary therapy, there has been a reduction in treatment-related morbidity. This improvement has been the direct result of a series of large multicenter trials. These trials have studied and refined the use of multimodal therapy, including chemotherapy, radiotherapy, and surgery, with great success. Rhabdomyosarcoma is the cause of 4% to 8% of all malignant disease occurring in children younger than 15 years and is one of the five most common malignant tumors of childhood. The first peak, encompassing more than 50% of cases, occurs in the first decade of life and is primarily embryonal or botryoid. This type tends to occur in the body cavities, the head and neck region, or the genitourinary tract with most patients alive 5 years after therapy. The second peak occurs during adolescence and consists largely of alveolar type, which are often seen in the extremities and metastasize early in the course of disease; these patients have a poorer prognosis. In this chapter, only tumors arising in the genitourinary tract are discussed further. Congenital and environmental factors have been shown to influence the incidence of rhabdomyosarcoma, however. In a large epidemiologic study, 5% of affected children were found to have a strong family history. Congenital Rhabdomyosarcoma Rhabdomyosarcoma is associated with Li-Fraumeni syndrome, neurofibromatosis, Noonan syndrome, BeckwithWiedemann syndrome,10 Costello syndrome,11 fetal alcohol syndrome, and basal cell nevus syndrome (Table 51-1). Typically, families have a history of premenopausal breast cancer, and the child is usually male and younger than 2 years. Independent of Li-Fraumeni syndrome, mutations of the p53 gene have been identified in 10% of children with rhabdomyosarcoma. Rhabdomyosarcoma of bladder and prostate were more common in this group of patients and did not seem to be different from other children with rhabdomyosarcoma in terms of prognosis. It may be classified as an overgrowth syndrome because of slightly increased birth weight and relative macrocephaly; it is characterized by severe postnatal failure to thrive and short stature. Acquired Rhabdomyosarcoma Many environmental factors have been implicated in rhabdomyosarcoma; these may work in conjunction with or independently of genetic risk factors. Chemical risk factors include chlorinated phenoxy herbicides, parental use of marijuana, parental use of cocaine, and maternal alcohol ingestion. This is a tumor that arises from a hollow organ, typically the vagina or bladder, and usually manifests as a prolapsing tumor resembling a bunch of grapes. The remaining tumors are normally firm and nodular; they appear to be well circumscribed when they actually are often infiltrating surrounding tissues. The international classification of rhabdomyosarcoma was defined based on the original Horn and Enterline classification because of a need to develop a single significant classification of rhabdomyosarcomas that is also prognostically meaningful. Rhabdomyosarcoma must be distinguished from neuroblastoma, Ewing sarcoma, and lymphoma. An adequate biopsy specimen is crucial for special histochemical stains and molecular studies; fine-needle biopsies are generally inappropriate. Malignant skeletal muscle differentiation distinguishes rhabdomyosarcoma from other round blue cell neoplasms. The cells are spindle-shaped or spindle-shaped and round in a loose myxoid or collagenous matrix. Classically, there is a dense tumor cell layer under the epithelium (cambium layer). An extensive degree of rhabdomyoblastic differentiation can be evident in the cambium layer and elsewhere in the neoplasm. The embryonal spindle cell variant also has a good prognosis, but is found only in paratesticular tumors and rarely in some head and neck lesions. More recent histologic and biologic studies have resulted in description of additional entities and refinements in recognition of the original entities, such as solid-alveolar rhabdomyosarcoma. Classification based solely chapter 51: Rhabdomyosarcoma 687 high levels in most rhabdomyosarcomas, even though the cells often show little differentiation. Embryonal and alveolar tumors can now be identified by different structural chromosomal changes. Although a single key genetic mutation cannot be identified in embryonal rhabdomyosarcomas, aberrations affecting the methylation status of key genes such as MyoD26 and p2127 have been identified. These findings suggest embryonal rhabdomyosarcoma may be epigenetic rather than genetic. Increased transcriptional levels of some growth factors or receptors in rhabdomyosarcomas are found to be associated with survival. The features are clusters of small round cells adherent to fibrous septa, giving the appearance of well-defined alveolar spaces. Occasionally, there are clusters of cells separated by fibrous septa, but the alveolar spaces are not present. Anaplastic (Pleomorphic) Rhabdomyosarcoma the category of pleomorphic rhabdomyosarcoma as originally defined by Horn and Enterline corresponds to the anaplastic group. They are characterized by various cell types from large cells with multiple nuclei to spindle-shaped cells. Anaplastic rhabdomyosarcoma was defined by large, lobate hyperchromatic nuclei and atypical mitotic figures. The occurrence of anaplasia is independent of either tumor site or subtype, although it occurs preferentially in embryonal rhabdomyosarcoma. Undifferentiated Rhabdomyosarcoma Some tumors are so undifferentiated that it is difficult to classify them. They are composed of primitive, small round cells that can often resemble Ewing sarcoma. With an increasing understanding of the immunohistochemistry of these tumors, undifferentiated tumors now can frequently be identified as rhabdomyosarcomas. Rhabdomyosarcoma tumors frequently express the muscle proteins actin, myosin, and desmin. Perhaps the most sensitive and specific group of proteins useful in the immunohistochemical diagnosis of rhabdomyosarcoma are muscle transcription factors MyoD and myogenin. These proteins, which define the earliest events in molecular determination of myoblastic lineage, are paradoxically expressed at Tumor Spread Rhabdomyosarcoma can spread by local infiltration into surrounding tissues. This depends on the site of the primary tumor, but it is unusual for tumors to spread into the rectum. Spread to local and regional lymph nodes is also a common feature, occurring in approximately 20% at presentation. Local Disease the most common presenting feature of the primary tumor site is the visible sign of the tumor. This can occur in two ways-either as a prolapsing mass seen with sarcoma botryoides or as a large abdominal mass (Table 51-3). These tumors often manifest as an abdominal mass because pelvic tumors can grow very large before they impinge on the surrounding rectum or bladder sufficiently to cause symptoms. Other presenting features are signs of bladder outlet obstruction or mucosal damage or both. In these patients, the site of the primary tumor may become apparent only after considerable investigation. In contrast to the situation with neuroblastoma and liver tumors, no specific serum or urine markers of rhabdomyosarcoma have been identified. In some patients, creatine kinase levels are increased, which can give a clue to the underlying diagnosis. Both should be performed using intravenous contrast material, with care being taken to record measurements of the tumor in at least two directions. In addition to visualization of the primary tumor site, the local and the regional lymph nodes must be identified. Edema after radiotherapy can be misinterpreted as residual disease in 20% of cases, using cross-sectional imaging techniques. Gadolinium enhancement is probably best avoided because it can lead to layered contrast material in the bladder, which can confuse interpretation. Imaging Accurate reproducible imaging is vital to the successful management of children with rhabdomyosarcoma. Imaging is required to identify the organ of origin and to assess the surgical management options. In addition, after therapy is initiated, imaging is used to monitor tumor responses. Despite this, T1-weighted and T2-weighted images in coronal and sagittal planes provide the best imaging on which to base clinical decisions. Historically, contrast cystograms and intravenous urograms were used to outline bladder lesions; however, extravesical spread of the lesion was difficult to assess. Distant Spread At the initial presentation, distant metastases are present in 25% of patients; consequently, the common sites for distant metastases require imaging. Bone scintigraphy, similar to all investigations, has false-negatives and identifies lesions in only 4% of patients. Endoscopy Patients in whom tumor in the bladder or vagina and uterus is suspected on clinical and radiologic investigations require endoscopy. Endoscopy can be used to delineate further the extent of the tumor and obtain tissue biopsy specimens. The advantages of endoscopic biopsy are that the risk of needle tract seeding is eliminated, and it is less invasive than open biopsy. Technically, obtaining a satisfactory biopsy specimen for tissue diagnosis can be difficult. Where possible, the biopsy specimen should be taken as close to the bladder or vaginal wall as possible; this should ensure sufficient tissue for diagnosis. In rare patients, accurate tissue diagnosis cannot be made using endoscopic biopsy, and an open or percutaneous method is necessary. GroupI-LocalizedDisease,CompletelyResected Regional nodes not involved A-Confined to organ of origin B-Contiguous involvement-infiltration outside the organ of origin Notation: this includes gross inspection and microscopic confirmation of complete resection. Surgeon believes that all the tumor has been removed, but pathologist finds tumor at the margin of resection, and additional resection to achieve a clean margin is not feasible. Differential Diagnosis Although rare, numerous tumors can mimic pelvic rhabdomyosarcoma (Table 51-4). In patients who present with a prolapsing tumor indicating sarcoma botryoides, vaginal prolapse, urethral prolapse, prolapsing ureterocele, and rare urethral polyps should be excluded. One of the difficulties inherent in this system is that the staging depends on the surgical excision. This can lead to interpatient staging variability, depending on the extent of surgical resection individual surgeons perform. This system has been modified to take into account the different outcomes associated with sites. This difficulty can lead to errors in pretreatment staging; however, with improvements in imaging techniques, the incidence of staging errors should be reduced. If bladder drainage is required, urethral catheterization is preferred because suprapubic drainage has resulted in the seeding of malignant cells along the tract, leading to local recurrence. If possible, the tissue specimen should be obtained endoscopically to avoid tract seeding; if this is not possible, the approach to biopsy requires careful consideration. Ideally, the site of the Tru-Cut biopsy should be planned so that at excisional surgery the biopsy site can be incorporated in the surgical incision. Generally, an adequate biopsy specimen can be obtained using a Tru-Cut needle; rarely, a surgical biopsy is required. The identification of new treatment targets through gene expression analyses, such as p53 and met, holds great promise for treatment of rhabdomyosarcoma. Radiotherapy as adjunctive therapy is able to damage and destroy malignant cells that remain after surgery and malignant cells in areas that are technically challenging for surgical removal. Radiotherapy is now restricted to patients with residual or metastatic disease, and a dose of 40 to 60 Gy is normally used; in very young children, this dose may be reduced. Metastatic sites require some form of imaging (but not histologic confirmation except for bone marrow examination) confirmation. Curative Treatment All patients with rhabdomyosarcoma are presumed to have micrometastatic disease at diagnosis. The current standard treatment includes a combination of chemotherapy with or without adjuvant radiotherapy and surgical excision as a specific treatment directed at control of primary site. From these studies, many agents, such as actinomycin D, cyclophosphamide, vincristine, and doxorubicin, were found to be effective, although few patients were cured.

Additionally medications for rheumatoid arthritis buy 600 mg oxcarbazepine mastercard, the Acute Myelomonocytic Leukemia A mixture of malignant cells with myelocytic and monocytic features is found in the blood and bone marrow of patients with acute myelomonocytic leukemia symptoms ketoacidosis 600 mg oxcarbazepine free shipping. The bone marrow has greater than 20% blasts medicine 6 year 300 mg oxcarbazepine purchase, with myeloid cells and monocytic cells each constituting greater than 20% of all marrow cells medications at 8 weeks pregnant purchase oxcarbazepine australia. The monoblasts are large cells with abundant symptoms exhaustion cheap oxcarbazepine uk, basophilic cytoplasm having fine azurophilic granules and often showing pseudopod cytoplasmic extensions; the nucleus has a lacy chromatin and one to four nucleoli. Promonocytes have a more convoluted nucleus with a more condensed, mature chromatin pattern and may have cytoplasmic vacuoles. The monocytic component may be more prominent in the peripheral blood than in the bone marrow. The nuclear chromatin of promonocytes is more condensed, and these cells often have a convoluted or cerebriform configuration. The cytoplasm of promonocytes contains azurophilic granules and may be vacuolated. The distinction between monoblastic and monocytic leukemia subtypes depends on the proportions of monoblasts and promonocytes present in the bone marrow. Acute monoblastic leukemia has a predominance of monoblasts, which are large cells with moderate to intensely basophilic, abundant cytoplasm and prominent round nuclei with fine chromatin. Characteristic positive immunoreactivity of monocytic leukemic cells for lysozyme is also a common finding. Acute monoblastic leukemia may occur at any age, but most patients tend to be younger, with increased blast percentages in the peripheral blood, and with a poor prognosis. A hallmark clinical feature of monocytic leukemias is extramedullary disease, and the most predominant finding is the cutaneous and gum infiltration, which results in gingival hypertrophy. There is a strong association between acute monocytic leukemia and the translocation t(8;16)(p11. Generally, acute monoblastic leukemia and acute monocytic leukemia have an unfavorable prognosis because of shorter duration of treatment response and poor prognostic factors. Acute Erythroid Leukemia Acute erythroid leukemias are predominantly characterized by abnormal proliferation of erythroid precursors. The additional presence or absence of a myeloid element defines the two subtypes, erythroleukemia or pure erythroid leukemia. More than 50% of bone marrow cells are erythroid precursors, and at least 20% are myeloblasts in erythroleukemia (erythroid/myeloid). Pure erythroid leukemia is defined by most marrow cells (greater than 80%) comprising erythroid precursors, without a myeloid proliferation. The differential diagnosis includes megaloblastic anemia; however, patients with vitamin B12 or folic acid deficiency respond to treatment with these vitamins, and the dysplastic features are not as pronounced as those dysplastic features seen in cases of erythroleukemia (erythroid/myeloid). Myeloblasts containing Auer rods may be observed in up to two-thirds of patients with erythroleukemia (erythroid/myeloid). It is interesting to note, however, that the crowding of the normal elements of the bone marrow by the leukemic cell population results in ineffective erythropoiesis, which leads to reticulocytopenia. Pure erythroid leukemia is the rarer subtype of the two acute erythroid leukemias and may be seen in patients of any age. The stem cells in this leukemia give rise predominantly to erythroid lineage; any myeloid cell markers are negative. The pronormoblasts can be identified by immunohistochemical reactivity with antibody to Hgb A and expression of glycophorin A, a red blood cell membrane protein. This diagnosis is made if at least 20% blasts in the bone marrow are observed and if at least 50% of these are megakaryoblasts. Although adult patients usually present with the typical acute leukemia symptoms related to cytopenias of pallor, weakness, and excessive bleeding, in contrast to other leukemias, organomegaly is uncommon at diagnosis. Thrombocytosis may rarely occur, and dysplastic features of platelets, immature myeloid, and erythroid cells may be seen. Megakaryoblasts are small or medium-to-large in size and are often found as a heterogeneous mix in the same patient in regard to size, with some blasts being small or medium with scant basophilic cytoplasm and others being much larger with more abundant cytoplasm and distinct blebbing pseudopod formation. The nucleus is round or slightly indented with delicate chromatin and one to three prominent nucleoli. Although megakaryoblasts may be difficult, if not impossible, to identify by light microscopy, the presence of blasts with cytoplasmic blebbing may provide a hallmark clue regarding the lineage of the blasts. Megakaryoblastic fragments or micromegakaryocytes and giant, hypogranular platelets are sometimes present. Megakaryoblasts manifest platelet peroxidase activity that can be identified by electron microscopy cytochemistry. Dysplastic myeloid precursors and dysplastic megakaryocytes (small, hypolobulated with eosinophilic granules) may be observed. Myeloid Sarcoma Myeloid sarcoma is defined as a tumor that consists of myeloblasts with or without any significant myeloid maturation that is found in the lymph nodes, bone, gastrointestinal tract, skin, or any soft tissue. In 20% to 30% of cases, acute megakaryoblastic leukemia may develop in subsequent years. Blastic Plasmacytoid Dendritic Cell Neoplasm Blastic plasmacytoid dendritic cell neoplasm is a very rare but aggressive tumor that can develop at any age but usually is seen in adults. The plasmacytic dendritic cells are medium-sized blasts with irregular nuclei, one to two small nucleoli, and fine chromatin. Patients present with one or more skin lesions that may appear as nodules or plaques and bone marrow involvement. Cytopenias may be minimal early on, but as the disease progresses and bone marrow failure is evident, the cytopenias intensify. These include leukemias in which the morphologic, immunophenotypic, or cytochemical findings are not helpful in the classification of a particular type of myeloid or lymphoid process or, conversely, in which the features indicate a combination of both processes. Clinical Features Clinical presentation is variable; symptoms may be subtle and develop over months, or they may be acute and quite severe. The presenting symptoms are directly related to the degree of bone marrow failure or extramedullary involvement (see Table 11. In about half of patients, symptoms include fever that stems from the leukemic process itself (tumor burden) and from neutropenia, pallor, and fatigue that are caused by anemia. Bleeding, purpura, and bone and joint pain are other common presenting complaints. Children often present with a limp or the inability to walk because of pain caused by leukemic infiltration of the periosteum (bone covering) or bone itself, causing osteoporosis or bone erosion. Uncommon symptoms include cough, dyspnea, cyanosis, and syncope related to a bulky mediastinal mass that can compress blood vessels or the trachea. The immunophenotype reflects the antigen expression of the stage of differentiation of the dominant clone. The leukemic cells persistently accumulate in intramedullary and extramedullary sites, constantly competing with normal hematopoietic cell production and function. This situation results in anemia, thrombocytopenia, neutropenia, and an overpopulation of lymphoblasts in tissues such as liver, spleen, lymph nodes, meninges, and gonads. L1 lymphoblasts are small with scant cytoplasm, are uniform in size, and have indistinct nucleoli. L2 blasts are larger, are more pleomorphic, and often contain abundant cytoplasm and prominent nucleoli (Table 11. L3 lymphoblasts are characterized by intensely basophilic cytoplasm that has many vacuoles. Environmental agents such as ionizing radiation and chemical mutagens have been implicated, and evidence suggests a genetic factor in some patients. It has also been postulated that some cases of childhood leukemia stem from adverse cellular response to common infections that occur at a later age than was typically experienced in past centuries. As with all other acute leukemias, anemia and thrombocytopenia are apparent at diagnosis. The blood and bone marrow contain lymphoblasts with small, scanty cytoplasm and condensed nuclear chromatin approximately twice the size of normal small lymphocytes or larger blasts with a moderate amount of basophilic cytoplasm, prominent nucleoli, and homogeneous, more dispersed nuclear chromatin. Lymphoblasts with pseudopod projections, termed "hand-mirror cells," may be found occasionally. Although not as important as the immunophenotypic characterization, cytochemistries may be helpful until further studies can be performed to help separate the preliminary diagnosis of lymphoid from myeloid leukemia. When the leukemic process is limited to a mass lesion and 25% or less lymphoblasts are seen in the marrow, the designation lymphoma is used. Immunophenotype As previously noted, immunologic classification should be performed in all cases because it allows for more precise diagnosis and important prognostic correlations. Because no one surface marker is 100% specific, a panel is needed to establish the diagnosis and sort the leukemia into the appropriate subtype. Each of the two lineages of lymphocytes (B cells and T cells) can be subclassified into several maturational stages by the expression of their surface antigens. Antigen Independent Stem Cell Early Pre-B Cell Pre-B Cell B Cell Antigen Dependent Plasma Cell Immat. These abnormalities are used to define the specific subtype and are discussed subsequently. Hyperdiploidy can be detected by routine karyotyping, flow cytometry, or fluorescence in situ hybridization analysis. Previously, this genetic subtype was associated with a poor prognosis; however, current therapy has produced a more promising prognosis. When the leukemic process is limited to a mass lesion, and 2% or less of lymphoblasts are seen in the marrow, the designation lymphoma is used. It is more prevalent in adolescents than young children and is seen more frequently in males than females. The two most important tests having the greatest prognostic prediction power when the sample of hematopoietic material is limited are flow cytometry and cytogenetics. Good communication between the clinician, the laboratory staff, and the pathologist is now even more imperative in gathering the important prognostic data to apply the most specific diagnosis and treatment. On examination, she was observed to have a tonsillar abscess, swollen glands, and widespread bruising in the extremities. She was treated with antibiotics and released, but she failed to progress over the next 2 days. The peripheral blood differential count revealed 3 band neutrophils, 25 segmented neutrophils, 8 lymphocytes, 1 monocyte, and 63 blasts. A bone marrow examination was performed and revealed an infiltration of blast cells in the marrow. The depressed hematocrit and platelet count indicate that the blast burden in the bone marrow is crowding out all the normal elements, causing low counts. The differential count results indicate an acute leukemia; however, further immunophenotype and genetic testing is needed to classify the type of acute leukemia. This girl will be transferred to an oncology facility and most likely will be treated aggressively after her leukemia is appropriately classified. Acute promyelocytic leukemia has a high incidence of which of the following cytogenetic abnormalities Which cytochemical reaction is most helpful in identifying the blasts in acute monoblastic leukemia The monoclonal marker that is often positive in B lymphoblastic leukemia/B lymphoblastic lymphoma is a. The basic pathophysiology mechanism responsible for producing signs and symptoms in leukemia includes all of the following except a. Migration to extramedullary sites is a feature of which of the following leukemias Meningeal leukemia Myelodysplasia central nervous system · Leukemic cells proliferating in the · Abnormal maturation or differentiation, or both, of granulocytes, erythrocytes, monocytes, and platelets · Gene that is responsible for the development 19. Two cases of disease and enlargement of the spleen in which death took place from the presence of purulent matter in the blood. Classification, pathogenesis, and etiology of neoplastic diseases of the hematopoietic system. How to differentiate neoplastic fever from infectious fever in patients with cancer: Usefulness of naproxen test. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 3rd ed. Extramedullary myeloid tumors: An immunohistochemical and morphologic study of 28 cases. Review of terminal deoxynucleotidyl transferase: Biologic aspects, methods of detection, and selected diagnostic application. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: A cooperative study. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias. Diagnostic and prognostic factors in acute monocytic leukemia: An analysis of 51 cases. Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia of infants/children and a review of 39 cases: Report from a t(1;22) study group. Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavorable cytogenetics and P-glycoprotein over-expression. High-contact paternal occupation, infection and childhood leukaemia: Five studies of unusual population mixing of adults. Superior vena cava syndrome associated with childhood malignancy: Analysis of 24 cases. Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Chapter 12 Chronic Myeloproliferative Disorders Kathleen Finnegan Introduction to Chronic Myeloproliferative Disorders New World Health Organization Classification Objectives After completing this chapter, the student will be able to: 1. Identify and differentiate clinical features and signs associated with chronic myeloproliferative disorders. Identify and describe the peripheral and bone marrow abnormalities associated with chronic myeloproliferative disorders. Compare and contrast the clinical and laboratory features of chronic myeloproliferative disorders. Discuss the cytogenetic abnormalities associated with chronic myeloproliferative disorders. Significant changes have evolved in the last decade with regard to terminology of leukemias and associated disorders.

Cheap oxcarbazepine 300 mg buy online. The Office - Business Ethics (Episode Highlight).

To prevent this complication medications to avoid during pregnancy order oxcarbazepine american express, Elder199 recommended that the site of the old reservoir drainage tube be used for percutaneous access because at this point the augmented segment is fixed to the anterior abdominal wall medicine 74 cheap 600 mg oxcarbazepine mastercard. When treating patients endoscopically via either transurethral or percutaneous access symptoms graves disease discount 600 mg oxcarbazepine with amex, it may prove challenging to remove all the fragments from a large medicine 014 generic 150 mg oxcarbazepine with amex, irregular reservoir medicine 834 purchase cheap oxcarbazepine on line. Although there was no statistically significant difference between the two treatment groups, Kronner and coworkers195 observed that 6 (54%) of 11 patients treated endoscopically had recurrent stones compared with 5 (33%) of 15 treated with open surgery. Although it is more invasive than endoscopic techniques, open cystolithotomy is still an alternative to augmented reservoirs or in departments in developing countries that are not fully equipped. The procedure is generally simple and fast and requires a short hospital stay with a minimal morbidity. When the urethra is normal, the main concern is to avoid urethral trauma with the risk of subsequent stricture. Usually the best option is to dislodge the calculus and push it back to the bladder, where it is fragmented. When the stone is associated with a urethral stricture or urethrocele, both treatment Urethral Calculi Urethral calculi are almost exclusively a male pathology. Either they come from the bladder and are stopped in their migration because they are too large for the caliber of a normal urethra, or they are a result of urinary stasis above a urethral stricture or within a urethrocele. In both cases, they are usually revealed by infection, pain during micturition, or acute urinary retention. C, Under general anesthesia, the patient was placed in a left lumbotomy position, and using three 5-mm ports, the calculus and a vascular loop were identified. Pediatric urologists can assume that they will be involved in the care of these patients as a primary or consulting provider. In contrast to adult cancers, in which environmental exposures are a significant causal factor, pediatric cancers are often associated with identifiable genetic events. The clinician must be familiar with these events to understand prognostic molecular features of pediatric tumors, counsel families, and interact with colleagues. Support for this theory comes from factors including similarities in structure between it and other known transcription factors, such as an amino terminus rich in prolines and glutamines. Recent decades have seen a dramatic increase in understanding of the genetic and molecular features of this cancer. Today, the focus of therapy is on tailoring treatment without compromising survival and expanding knowledge of the molecular biology of this cancer. The connection between the two was initially identified by familial-linkage studies and cytogenetic analyses. The specific gene responsible at 11p15 has not been identified, but several candidate genes have been suggested. The first may occur as a result of inheritance of a germline mutation or a de novo germ cell aberration. These patients are predisposed to tumor development, requiring only one other event, or "hit," for a tumor to develop. The most commonly described scenario that fits the Knudson model is the inactivation of both alleles of a tumorsuppressor gene. An arginine-to-tryptophan change in exon 2 is the most common finding in patients with Denys-Drash syndrome. The relationship of Beckwith-Wiedemann syndrome to 11p15 abnormalities was discovered on the basis of familial linkage syndromes. These studies showed either paternal duplication (paternal trisomy) or inheritance of two paternal chromosomes (unipaternal isodisomy). Focal anaplasia or anaplasia confined to one or a few discrete loci within a tumor carries a better prognosis than diffuse anaplasia. We briefly review the principal risk factors before discussing principles of therapy. Patients with p53 abnormalities seem to do poorly relative to patients without p53 abnormalities. Tumors that are locally advanced or metastatic carry a worse prognosis than tumors that remain localized. This fundamental difference precludes stage-by-stage comparisons of patients enrolled in the two groups. The authors concluded that "survivors of childhood cancer have a high rate of illness owing to chronic health conditions. Five patients had pulmonary relapse, three had flank disease, and three had contralateral disease. The study was stopped because initial stoppage criteria were met; however, the salvage rate for relapsing patients treated with chemotherapy and radiation was 91%. Based on these findings, the current protocol calls for nephrectomy only in young patients with low-volume disease. Future studies are expected to provide insight into the role of chemotherapy in preventing metachronous contralateral tumors arising from nephrogenic rests. This group of patients would continue to receive three-drug therapy and radiation, and would be classified as "standard risk. Further analysis showed a significant positive correlation between dose of radiation and risk of secondary cancer. Cardiovascular Disease Treatment with doxorubicin is a known risk factor for cardiovascular disease. The first is to attempt to spare a subgroup of patients with pulmonary metastasis radiation therapy. This protocol would exempt patients who respond to three-drug therapy with disappearance (as shown by computed tomography scan) of all pulmonary metastasis by week 6 of treatment from pulmonary radiation. This protocol is modeled after a similar successful approach adopted by European investigators. Pulmonary Complications Pulmonary complications have been primarily associated with radiation exposure to the lungs. Group 4 comprised group 1 and 2 patients who went on to receive pulmonary radiation therapy. Patients with focal or diffuse anaplasia are enrolled in a separate high-risk protocol. Total incidence was reported to be 17% among patients with bilateral disease and 1% among patients with unilateral disease. Duration of pregnancy and birth weights of newborns were significantly negatively affected by a history of radiation exposure. Available data also suggest that female patients undergoing abdominal/pelvic radiation have a poor outlook for fertility. Currently, no molecular markers have been identified, and the pathogenesis of the lesion is poorly understood. With modifications of the abovementioned regimen, it is hoped that overall survival for all stages will exceed 75%. A review of various series indicates that prognosis is not affected by adjuvant treatment. Previously, it was believed that this subtype made up greater than 90% of bladder/prostate tumors. Tumors are composed of spindle-shaped cells with a central nucleus in an eosinophilic cytoplasm. In contrast, diffused nuclear staining of myogenin or MyoD1 is seen with alveolar rhabdomyosarcoma. The spindle cell variant of embryonal rhabdomyosarcoma is most common in the paratesticular region, and typically carries an excellent prognosis. Alveolar rhabdomyosarcoma occurs most frequently in older children and histologically resembles 10- to 21-week gestational age striated muscle. Histologic features include clusters of small round cells that are adherent to fibrosepta, creating well-defined alveolar spaces; cross-striations are uncommon. Understanding of the molecular basis of this lesion has been advanced by the recognition that it harbors distinct molecular alterations, such as t(2;13) or t(1;13) translocations. Pleomorphic rhabdomyosarcoma is not commonly found in the bladder or prostate of children. This tumor can be confused with Ewing sarcoma, and in difficult cases, identification of t(2;13), t(1:13) translocations specific for rhabdomyosarcoma or t(11:22) specific for Ewing sarcoma can be helpful. Although the similarity of this model to human rhabdomyosarcoma is unclear, the authors describe a unique animal model for further study. Prognosis In addition to stage of disease and treatment risk groups, histologic classification continues to be one of the strongest predictors of outcome in rhabdomyosarcoma (Table 49-3). Prognostic Significance of Rhabdomyoblasts Significant controversy has surrounded the identification of rhabdomyoblasts in post-treatment specimens. Analysis of postcystectomy specimens has shown rhabdomyoblasts with a reduction in cellularity in patients treated with chemotherapy, suggesting that this pattern may be indicative of response to therapy. Initial case reports suggested that observation was appropriate for these patients. Ortega and associates102 followed six patients with posttreatment biopsy showing mature rhabdomyoblasts. All six patients remained disease-free after a follow-up period of 37 to 237 months. Mature cells with a large smooth solitary nucleus, no significant pleomorphism, no mitotic activity, and the absence of clusters of cells suggestive of growth from a common precursor are the essential features of the diagnosis. At week 13, additional local control can be performed for patients who can safely undergo delayed primary excision. High-Risk Group the high-risk group consists primarily of patients with alveolar and undifferentiated rhabdomyosarcoma and patients older than 10 years with embryonal tumors and metastatic disease. Specifically, patients would receive intervalcompressed cycles of vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide. Patients also would receive an up-front window of vincristine/irinotecan to assess further the response of this combination in previously untreated high-risk patients. Irinotecan also would be used in conjunction with radiotherapy, as a radiosensitizer. Tolerability and toxicity of this combination have not been studied previously in children and would be assessed in this study at weeks 19 to 23. A broad overview highlighting principles of chemotherapy and radiation therapy follows. The apparent preliminary success of bladder preservation has drawn particular attention to late effects related to genitourinary tract function. Current protocols attempt to reduce the cumulative doses of cyclophosphamide in this population to limit toxicity. The low-risk group would be divided into two subsets based on stage, location, and clinical group. Patients in subset 1 would go on to receive another four cycles of actinomycin-D and vincristine (V), whereas patients in subset 2 would continue V for another 12 weeks. Timing of radiation continues to be a controversial subject in patients with rhabdomyosarcoma. Mechanisms of Bladder Injury Surgery, chemotherapy, and radiation therapy all may individually cause bladder dysfunction. Partial cystectomy can also adversely effect innervation, however, and function of the bladder. In the series by Yeung and colleagues,114 only the four children who did not receive radiation had normal bladder function. Similarly, Raney and associates115 noted that 13 of 43 patients receiving radiation had bladder dysfunction compared with 1 of 9 nonirradiated patients. Hays and associates116 reported that 9 of 19 irradiated patients had long-term bladder sequelae versus 1 of 11 treated without radiation. A dose effect was suggested in this study: 1 of 6 patients receiving less than 40 Gy had dysfunction as opposed to 8 of 13 receiving more than 40 Gy. Acute injury is characterized by an inflammatory response within the bladder wall that reduces bladder storage capacity. In the current protocol, irinotecan is combined with vincristine in a randomization arm. Irinotecan belongs to a newer class of chemotherapeutic agents (topoisomerase I inhibitors) and has shown promise in phase I studies. Overall 6-year survival was 82%; however, event-free survival was 77% at a mean of 6. Of 55 patients who retained their bladders, only 36 (40%) had "normal" bladder function. Urodynamics and standardized questionnaires were not used, suggesting that the true extent of dysfunction may be greater. Of patients 6 years old or older, 31% had urinary incontinence; 27% of patients who had undergone partial cystectomy had similar complaints. Fifty-five percent of patients had recurrent urinary tract infections, 40% had decreased renal function, and 25% had hematuria. The other four patients had urologic complaints, and their urodynamic findings included reduced bladder capacity in four, overactivity in two, urgency in three, and suprapubic pain during filling. There is a paucity of objective data regarding bladder function in patients treated for bladder/prostate rhabdomyosarcoma. Although many authors have reported reasonable bladder function after therapy, objective analysis with urodynamics, standardized questionnaires, or imaging has not been performed. The severity of late effects is related to radiation dosage and may include symptoms such as urgency, frequency, hematuria, and diminished bladder compliance. Increased transforming growth factor- expression resulting in altered collagen deposition has been implicated. Other potential solutions include better radiation targeting and the use of brachytherapy. Objective data are lacking regarding bladder function in children treated for rhabdomyosarcoma. Yeung and colleagues114 evaluated bladder function in 11 children with tumors involving the bladder base or prostate or both (6), the pelvic wall (2), the vagina (2), and the bladder dome (1).

T cells play a vital role in cell-mediated and humoral response and are essential to immune development symptoms vomiting diarrhea generic oxcarbazepine 600 mg with visa. These antigens are determined through a series of monoclonal antibodies manufactured by public and private companies to identify surface antigens on the many lymphocyte (and other cell) subsets symptoms ketoacidosis purchase oxcarbazepine without prescription. Lymphocytes can be identified at successive stages in their maturation by their pattern of reaction to monoclonal antibodies medicine to treat uti discount oxcarbazepine 150 mg otc. The age of the patient directly influences whether this number is within or outside of the reference range (Table 9 medicine assistance programs discount oxcarbazepine 150 mg buy on-line. Generally symptoms joint pain fatigue buy oxcarbazepine 150 mg without a prescription, the differential is performed on a well-stained, well-distributed peripheral smear. T helper cells interact with monocytes and macrophages, secrete cytokines, and promote humoral immunity. T cytotoxic cells promote memory cells and help to eliminate nonself by promoting enzyme activity, which can significantly alter the cell membrane. B cells, which represent 10% to 20% of total lymphocytes, differentiate into plasma cells. Lymphokines help B lymphocytes transform into plasma cells, detect antigens, and produce antibodies. These cells are non-T or non-B in origin and do not need antigenic stimulation to function. Originating in the bone marrow, their primary role is resisting bacteria, viruses, and fungi. Next, a differential count is performed; 100 white blood cells are counted, and the percentage and identification of each type of white blood cell are recorded. These percentages are compared with the reference ranges for an individual according to age (Table 9. White blood cell estimates provide important quality control data for the technologist performing the differential. A white blood cell estimate that fails to agree with the automated count may indicate that the wrong smear was pulled, warranting an investigation to correct this error. In most cases, 100 white blood cells are carefully counted and identified, but there are circumstances that may warrant counting 200 white blood cells. Students need to refer to the standard operating procedure at each clinical site for recommendations for counting a 200-cell differential. These values are usually flagged by the automated instrument and must be reported to the physician or the pathologist, or both, in a timely fashion. Laboratory personnel keep careful records concerning notification of a patient with a critical value. Manual Differential Versus Differential Scan Most automated hematology instruments have the capacity to perform a differential count. This advance in instrumentation has dramatically shifted work patterns because less time is spent in reviewing peripheral smears. When a differential is ordered and reported from instrumentation, there are some conditions in which the automated differential count may be questionable. If certain parameters in the differential have been flagged or if a peripheral smear requires review because of a delta check or reflex testing, the peripheral smear is reviewed by a laboratory professional. In these circumstances, there are two levels of technologist review: a manual leukocyte differential count or a differential scan (diff scan). A manual leukocyte differential count implies counting 100 white blood cells along with red blood cell morphology and platelets estimate. A differential scan implies that approximately 50 cells are reviewed to verify the automated result. The criteria for performing either a full differential count or a differential scan are usually well outlined in the standard operating procedure for each clinical facility. Generally, these criteria include items such as total leukocyte count, lymphocytes, and monocytes above a certain level; an abnormal scatter plot; or thrombocytopenia. Patients whose peripheral smears need review usually are seriously ill or their conditions Table 9. For criteria for performing a manual differential, refer to the standard operating procedure for each facility. Reviewing peripheral smears on these patients requires a high level of morphologic skill from the laboratory professional. Reference range for absolute lymphocyte count = 1700 to 3500 In this patient, there is a relative lymphocytosis but not an absolute lymphocytosis. No further testing was ordered because it was the weekend, and a hematology consultation could not be arranged before Monday. When the peripheral smear was stained and reviewed, the technologist noted that most of the platelets were spreading around the neutrophils, a condition known as platelet satellitism. Ordinarily, a flag on the platelet count probably would not warrant a peripheral smear review. This situation may serve as a catalyst, however, for reviewing the flagging policy. In which stage of neutrophilic maturation are specific secondary granules first seen Lymphocyte concentrations in peripheral blood are greatest during what age interval One of the primary glands in an infant responsible for lymphocyte origination is the a. A 74-year-old patient in the critical care unit was having daily hematology blood work performed. The second sample was sent 20 minutes later with a request for hemoglobin and hematocrit. The procedure when drawing through an A line is to draw off and discard the first 10 mL of blood and then proceed with the blood draw, usually filling tubes directly from the line. In this case, the blood draw for the first sample was difficult, and the blood from the A line was not free flowing. After consultation with the lead technologist and the nurse, it was decided to release the second set of results and remove the first set from the computer. The patient had a blood bank history and had received units of packed red blood cells and fresh frozen plasma. Cell biology, disorders of neutrophils, infectious mononucleosis and reactive lymphocytes. B lymphopoiesis is active throughout human life, but there are developmental age related changes. Chapter 10 Abnormalities of White Blood Cells: Quantitative, Qualitative, and the Lipid Storage Diseases Betty Ciesla Introduction to White Blood Cell Disorders Quantitative Changes in White Blood Cells Conditions With Increased Neutrophils Conditions With Increased Eosinophils Conditions With Increased Basophils Conditions With Increased Monocytes Conditions That Decrease Neutrophils Conditions That Decrease Eosinophils Conditions That Decrease Basophils Conditions That Decrease Monocytes Specific Terminology Relating to Quantitative White Blood Cell Changes Objectives After completing this chapter, the student will be able to: 1. Identify conditions that cause a quantitative increase or decrease in a particular white blood cell line. Compare and contrast the acquired and inherited qualitative changes in the white blood cell. Identify conditions that lead to hyposegmentation or hypersegmentation of segmented neutrophils. Describe the process of reactive lymphocytosis in infections with Epstein-Barr virus and cytomegalovirus. Define white blood cell­related terms such as leukocytosis, left shift, leukemoid reaction, and leukoerythroblastic reaction. Infection, inflammation, chronic disease, and parasitic infestations all are examples of an unexpected occurrence and an opportunity for white blood cells to mobilize. As white blood cells respond to infection or other stimuli, changes are seen in the number and types of a particular cell line. When a cell line is increased, the suffix used to designate an increase is "osis" or "philia". When a cell line is decreased, the suffix used to designate a decrease is "penia". An interesting situation is the role that granules from a particular cell line play in producing symptoms. When histamine is released from eosinophils, this chemical stimulates allergy-related symptoms such as watery, itching eyes and rhinorrhea. Most allergy medications contain antihistamines that are formulated to block allergy symptoms. In most cases, patients who have newly acquired infections show an increase in white blood cells from the reference range. These conditions are usually transient, and when the underlying condition has resolved itself, for the most part the counts return to normal. The role of the neutrophil in phagocytosis is localized and immediate; the role of the monocyte is related to immune response and is more tissue-oriented. The process by which bacteria are digested and immobilized can be broken down into several simplified steps. The release of interleukin-8 and complement helps neutrophils mobilize to site of infection. This occurs as a result of medications, bone marrow assaults secondary to chemicals, viral infections, or splenic sequestration. Stages depicted are (A) chemotaxis and directed motility, (B) opsonization, (C) ingestion, (D) degranulation and digestion. The pH of the cell is reduced, and hydrogen peroxide is produced by the neutrophil as a result of respiratory burst and released to accelerate the destruction process. Bacteremia or sepsis may occur if invading organisms or foreign bodies are not destroyed when they enter the body. The organisms may locate in secondary sites such as the lymph nodes, where they rapidly multiply and release toxins. Phagocytic activity is a complex process involving phagocytic cells, the complement system, cytotoxins, and acute-phase reactants. Each of these systems must have coordinated activities to ensure that pathogens are destroyed (Table 10. A careful and patient review of the peripheral smear of these individuals reveals many of the changes discussed. Toxic Changes in White Blood Cells the visible response of white blood cells to infection or inflammation occurs along two paths. As white blood cells increase, the peripheral smear usually shows either increased numbers of segmented neutrophils, giving rise to a neutrophilia, or a shift to the left, where younger cells are noted. In either of these cases, toxic changes, such as toxic granulation, toxic vacuolization, or the presence of Döhle bodies, may be observed. Careful examination of the neutrophils for these toxic changes is extremely important. Acquired defects are seen with much greater frequency than inherited Cell is altered Table 10. Toxic granulation is excessive in amount and intensity, with more prominent granules in segmented neutrophils and bands in direct response to enhanced lysosome enzyme production. Prolonged exposure of blood to drugs such as sulfonamides or chloroquine or prolonged storage may lead to phagocytosis of granules or cytoplasmic contents. In cases where the creation of peripheral smears has been delayed, pseudovacuolization can be recognized. Larger vacuoles unevenly distributed throughout the cytoplasm usually signal serious infections and possible sepsis. Studies have shown that when 10% of neutrophils are affected by vacuoles in a fresh sample, this ranks as a serious and significant prognostic indicator (Table 10. They range from 1 to 5 µm in size, are located near the cytoplasmic membrane, and appear as a rod-shaped, pale bluish gray structure. Döhle bodies are difficult to observe under light microscopy, and peripheral smears must be carefully scrutinized for their presence. Nuclear Abnormalities: Hypersegmentation Normal segmented neutrophils have between three and five lobes in the nucleus. Hypersegmentation is defined as a segmented neutrophilic nucleus having more than five lobes. This condition is usually seen in megaloblastic processes, such as folic acid deficiency, pernicious anemia, or vitamin B12 deficiency, and is usually accompanied by oval macrocytes. Human Ehrlichiosis Named for the noted microbiologist Ehrlich, human ehrlichiosis and anaplasmosis infections are a relatively new group of tick-borne diseases that show a notable white blood cell inclusion in some cases. These diseases are difficult to diagnose because patients present with vague symptoms that are often mistaken for other infectious diseases. Inclusions, known as morulae, may be seen in the granulocytes or monocytes from the bone marrow or peripheral smear; these inclusions are large (1 to 3 µm) and resemble berries in appearance. Döhle-like bodies are seen in the cytoplasm of neutrophils and are larger than the Döhle bodies seen in neutrophils responding to infections or inflammation. This granulation is thought to consist of lipid depositions in the cytoplasm as a result of decreased mucopolysaccharide production. In a true Pelger-Huët anomaly, almost 70% to 95% of the neutrophils show hyposegmentation. There are numerous conditions in which the neutrophils may have a pseudo­Pelger-Huët appearance, such as leukemias, myeloproliferative disorders, and severe infections. Chédiak-Higashi Syndrome Chédiak-Higashi syndrome is a rare autosomal disorder of neutrophilic granules. Current studies suggest that these individuals have a defective fusion protein, which is crucial to lysosomal secretion. Affected children show neutropenia, albinism, and photophobia and develop recurrent infections with Staphylococcus aureus. Platelet function is affected with abnormal bleeding times and small vessel bleeding. The prognosis is poor in most children, who usually die young because of complications of infections. Pelger-Huët Anomaly Pelger-Huët anomaly is a fairly common inherited disorder that shows hyposegmentation of the nucleus of segmented neutrophils. In heterozygotes, the nucleus is seen as peanut-shaped, dumbbell-shaped, or pincenez­shaped.

References

• Tobin JR Jr, Bay EB, Humphreys EM. Marfan's syndrome in the adult dissecting aneurysm of the aorta associated with arachnodactyly. Arch Med Interna 1947;80:475-90.
• Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant. 2000;6:44-49.
• Youssefzdeh, D., Katz, D.S., Lumerman, J.H. Unenhanced helical CT in the evaluation of suspected renal colic. AUA Update Series 1999;XVIII;Lesson 26.
• Hirano H, Tsuji M, Kizaki T, et al. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study. Med Electron Microsc 2002;35(1):16-23.